The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Head and Neck Neoplasms; Neoplasm Recurrence, Local; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Bayes Theorem; Cetuximab; Squamous Cell Carcinoma of Head and Neck
PubMed ID
36977289
Added to directory
Source checked

Report a correction or request removal